Pharmaceuticals & Biotech Businesses for Sale.

The compliance infrastructure, multi-year customer contracts, and switching costs built into regulated workflows are what make the best pharma and biotech businesses so hard for competitors to replicate.

Browse Listings Get new matching listings

A clay model of a biotech company in a Cambridge-style lab building, with the owner looking over the operation.

New This Month

Active Listings

$3.1M

Median Asking Price

Rejigg lists 21 pharmaceuticals & biotech businesses for sale. The median asking price is $3.1M. 1 of them was listed in the last 30 days.

Browse listings

Featured Pharmaceuticals & Biotech Businesses

Showing 21 of 21 listings

Search, filter, and find your perfect opportunity

What to know

What to know about buying a pharmaceuticals & biotech business

How pharmaceuticals & biotech businesses are valued

Asking prices are set as a multiple of earnings: 3x–12x annual profit, depending on recurring revenue, customer loyalty, and how much runs without you.

Where you land in that range depends on how much of your revenue comes from subscriptions that renew automatically, how loyal your customers are, and whether the business runs without you.

Customers who pay you every year automatically
Customers who'd have a hard time switching
Customers expanding to more locations
Compliance records all in order

What buyers of pharmaceuticals & biotech businesses look for

Software companies looking to add pharma compliance capabilities
Companies in adjacent pharma services like packaging or labeling
Healthcare-focused investment groups building a portfolio of regulated software companies
Experienced operators with pharma industry backgrounds looking to grow a founder-built company

The first questions buyers ask:

Rights & Assets. What exactly are you selling: an asset, a platform, or a regulated operation?
IP Cleanliness. Who actually owns the invention, and is the IP chain of title clean?
Quality System. Would your work survive a buyer’s audit? How do you run quality day to day?

Closed deals

Rejigg pharmaceuticals & biotech deals closed

Across 42 closed deals on Rejigg, the median time from first pitch to close is 177.5 days.

See all Rejigg deal data

Due diligence

What to Look For

Practical guidance from hundreds of real acquisition conversations.

Subscription Revenue Share

Ask what percentage of revenue comes from subscriptions or annual contracts that renew automatically versus one-time project work.
High recurring revenue changes the risk profile from day one and tends to support stronger financing terms.
A business where 60 percent or more of revenue is contracted and predictable is a very different starting point than a project-driven one.

Customer Switching Costs

In regulated industries, switching away from a compliance or traceability platform requires a full revalidation process that can cost hundreds of thousands of dollars and months of disruption.
Ask how embedded the product is in each customer's actual operations, not just how long they've been a customer.
Customers who would need months to revalidate before switching are the kind of retention story that holds through ownership changes.

Customer Tenure and Concentration

Ask for a customer list with tenure dates, even if names are anonymized early in the process.
Customers on the platform for five or more years without churning are a strong signal that the product genuinely delivers what it promises.
Check whether any single customer represents more than 20 to 25 percent of revenue, and spend time understanding that relationship if they do.

Compliance Documentation

Ask to see FDA records, validation documentation, and compliance certifications, and check that they're organized and current.
Missing or disorganized compliance records can slow the process down and create questions that are hard to answer quickly.
A seller with clean, well-maintained compliance files is signaling that the business has been run with real discipline.

Expansion Potential

Some of the best businesses in this space have proven their platform in one vertical and have clear, untapped potential in adjacent ones like animal health, food safety, or medical devices.
Ask where the product has already expanded and where it hasn't yet, which tells you a lot about the growth opportunity you'd be acquiring.
A proven platform in one regulated market with a natural path into a second is a meaningful strategic advantage.

Valuation

What Should You Expect to Pay?

3x-6x

SDE

Founder-dependent with some recurring revenue

6x-12x

EBITDA

With team running independently and high recurring revenue from long-tenure customers

The spread is driven by how much revenue is truly recurring, how embedded the product is in customer operations, and whether the business can run without the founder's direct involvement.

What drives a premium

Majority of revenue from annual subscriptions that renew without active sales effort

Customers deeply embedded in the platform with high switching costs due to revalidation requirements

Multi-year customer retention with documented tenure history across the customer base

Compliance records including FDA documentation and validation certifications organized and current

SBA Loan Calculator

See what your monthly payments would look like at different deal sizes

For buyers

Make your next conversation count

A listing starts the conversation. These tools help you check the fit, understand the financials, and decide what to ask next.

Prepare for the first owner call

Clarify what is for sale, who runs the business, and what the owner wants from a transition.

Prepare your buyer introduction

Check the numbers behind the asking price

Explore financing scenarios, debt payments, and the cash a business needs to keep operating.

Try the SBA loan calculator

Turn interest into a clear next step

Use the diligence checklist and LOI templates to organize requests and prepare a proposal.

Explore the deal templates

Find a business worth a closer look

Keep your industry and location in focus. Explore matching businesses or get new listings as they arrive.

Explore matching businesses Get new matching listings

Thinking About Selling?Read our owner's guide to selling a pharmaceuticals & biotech business, with valuation tips, buyer expectations, and step-by-step advice.

Read the Owner's Guide

Pharmaceuticals & Biotech Business Acquisition

How do I contact the owner of a business I found on Rejigg?

Create a free Rejigg account; owners, and the brokers who run some sales, only hear from buyers through the platform. Open the listing to see the full profile: city, team size, financials, what is for sale, and the reason for selling. Sign Rejigg's standard Fee & Confidentiality Agreement for that business; it is the same form for every deal. Verify your phone, then send your pitch from the listing. Replies, meetings, and documents all run through Rejigg.

Can I email Rejigg to get introduced to an owner?

No. Rejigg does not forward emails to owners or brokers, so a note to support@ or hello@ with a listing link will not reach them. Create a free account, open the listing, sign the agreement for that business, verify your phone, and send your pitch; that reaches them in a few minutes.

What exactly are you selling: an asset, a platform, or a regulated operation?

Buyers are clarifying what they are buying in legal and operational terms, such as IP, data, validated methods, QMS (Quality Management System) records, customer contracts, or a regulated facility. They also want to see whether anything blocks transfer, including consents, shared rights, missing deliverables, or registrations that force a restructure after the LOI.

Who actually owns the invention, and is the IP chain of title clean?

They are checking whether any founder, contractor, university, or collaborator can claim core IP after closing. If the chain of title is unclear, buyers usually protect themselves with escrows, closing conditions, price reductions, or an asset deal that narrows liability.

Would your work survive a buyer’s audit? How do you run quality day to day?

Buyers look for a QMS that works in practice, including deviations, CAPA (Corrective and Preventive Action), change control, training, supplier qualification, complaints, and release decisions. If they see workarounds or undocumented decision-making, they assume remediation after close, higher compliance risk, and slower integration. That often shows up as a lower price, a holdback, or tougher closing conditions.

How painful will it be to move or scale what you do? What’s validated versus just used?

They are estimating cost and timeline for integration, including re-validation, retraining, documentation rebuilds, and tech transfer risk for manufacturing, assays, and regulated software. A credible transfer plan lowers the fear that closing triggers months of remediation or a compliance event.

What lane are you in? What claims can you legally make today, and what’s the next agency interaction?

Buyers want the real regulatory classification, the history of agency interactions, and proof that current claims stay within the label, RUO (Research Use Only), or authorization boundary. They also assess whether a change of control or site move triggers notifications, supplements, re-approvals, or re-validation that affects closing and continuity.

Can we use the clinical and preclinical data after a change of control, and can we access the raw data?

They are confirming the buyer can rely on your studies for submissions, audits, and partner discussions, including access to underlying datasets. If ownership, access, or assignment terms are unclear across CROs, academic sites, biomarkers, or companion diagnostics, buyers assume they may need to repeat work or renegotiate with third parties.

Pharmaceuticals & Biotech Businesses for Sale.

Featured Pharmaceuticals & Biotech Businesses

Mushroom Wellness Products Business

Vitamins / Supplements Business

Chemical Supplier

Pain Management Medical Device Company

Custom Bioassay Research Solutions

Pharma Digital Creative Agency

Online Health and Wellness Store

At-Home Allergy Immunotherapy Platform

Heath Information Publication Business

Wellness Products Retailer

Biotech Drug Discovery Enzyme Supplier

Human Tissue Biotech Solutions

Biotechnology Research Company

Spectrometry & Research Services Company

Regenerative Healthcare Business

Life Sciences Medical and Laboratory Supply

Contract Pharmaceutical Testing Laboratory

Nutraceutical Business

Research Peptide Supply Lab

Pharmaceutical Analytics Business

Medical Weight Loss & Wellness Clinic